treatment guidelines

Research in Review

Mayo Clinic Outlines Pathways for Thrombotic Microangiopathies

09/06/2016

JCP Editors

Members of the Mayo Clinic in Rochester, MN, have provided guidelines for the creation of evidence-based clinical pathways for thrombotic microangiopathies (TMAs). TMAs are a diverse set of disorders sharing a...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Study Identifies Financial Ties Among NCCN Guideline Authors and Drug Industry

09/02/2016

JCP Editors

A new study that quantifies industry financial conflicts of interest (FCOIs) found that nearly nine out of 10 physicians and researchers who helped develop the National Comprehensive Network (NCCN) guidelines—work...

A new...

09/02/2016

Journal of Clinical Pathways

Research in Review

Aromatase Inhibitor-Treated Patients With Breast Cancer Lacking Necessary Testing

07/19/2016

JCP Editors

Older women most at risk for bone fractures may not be receiving recommended bone density assessments prior to receiving aromatase inhibitor (AI) treatment for breast cancer, according to a study published in the...

Older...

07/19/2016

Journal of Clinical Pathways

Research in Review

ESMO Magnitude of Clinical Benefit Scale Aids Cancer Decision-Making

07/14/2016

JCP Editors

A study out of the Medical University of Vienna, Austria, one of Europe’s largest cancer centers, asserts that the European Society for Medical Oncology (ESMO) Magnitude of Clinical Benefit Scale (MCBS) is a reliable...

A...

07/14/2016

Journal of Clinical Pathways

Conference Coverage

2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting

06/20/2016

JCP Editors

Founded in 1995, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is one of the leading organizations promoting the research of health economics and value-based care. Currently, ISPOR is...

...

06/20/2016

Journal of Clinical Pathways

Quality Measures for NSCLC Significantly Improve Survival

05/20/2016

JCP Editors

Including certain quality measures as a part of care for patients with non-small cell lung cancer (NSCLC) who undergo surgery can significantly improve survival, according to results presented at the American...

...

05/20/2016

Journal of Clinical Pathways

Counterpoint

Keeping Cures on the Shelf

05/06/2016

George Dahlman

Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...

...

05/06/2016

Journal of Clinical Pathways

Viewpoint

Chemotherapy Shortages: When is Enough, Enough?

05/06/2016

Yoram Unguru, MD, MS, MA

Shortages of life-saving chemotherapy agents and supportive care drugs have presented physicians treating children with cancer with difficult decisions regarding drug allocation and prioritization. Guidelines...

...

05/06/2016

Journal of Clinical Pathways

Research in Review

05/06/2016

JCP Editors

A look at more than 10 years of data has shown that many patients with ovarian cancer covered by Medicare are not receiving treatment consistent with National Comprehensive Cancer Network (NCCN) recommendations,...

...

05/06/2016

Journal of Clinical Pathways

Radiation Therapy Better for Testicular Cancer Than Chemotherapy

05/02/2016

JCP Editors

Radiation therapy may be superior to chemotherapy for patients with stage 2a-b testicular cancer, according to results presented at European Society for Therapeutic Radiology and Oncology (ESTRO) 35 (April 29-May 3,...

...

05/02/2016

Journal of Clinical Pathways